1 |
Methotrexate
| [1] Methotrexate Methotrexate | [6] Methotrexat Methotrexat; METHOTREXATE; METHOTREXATE SODIUM; Metoject; Metotrexato; Méthotrexate; | [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [38] 11 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 |
2 |
Trimethoprim
| [1] Trimethoprim Trimethoprim | [2] Bactrim Bactrim; Trimethoprim; | - | - | [8] 36 36, 44, 49, 60, 61, 85, 298, 299 |
3 |
Azathioprine
| [1] Azathioprine Azathioprine | [3] Azathioprine Azathioprine; Azatioprina; Imuran; | - | - | [21] 6 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 93, 94, 95, 96, 97, 162 |
4 |
Cyclophosphamide
| [1] Cyclophosphamide Cyclophosphamide | [6] Ciclofosfamida Ciclofosfamida; Ciclofosfamide; Cyclophosphamid; Cyclophosphamide; Cyclophosphamidum; Cytoxan; | - | - | [44] 11 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 274, 283, 284, 285, 288, 326, 331 |
5 |
Sulfamethoxazole
| [1] Sulfamethoxazole Sulfamethoxazole | [3] Bactrim Bactrim; Sulfamethoxazole; Sulphamethoxazole; | - | - | [5] 44 44, 49, 61, 85, 299 |
6 |
Prednisolone
| [1] Prednisolone Prednisolone | [3] Prednisolona Prednisolona; Prednisolone; Prednisolonum; | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [42] 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300 |
7 |
Prednisone
| [1] Prednisone Prednisone | [3] PREDNISONA PREDNISONA; Prednisone; RAYOS; | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [45] 2 2, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331 |
8 |
Mycophenolate mofetil
| [1] Mycophenolate mofetil Mycophenolate mofetil | [3] CELLCEPT CELLCEPT; Mycophenolate mofetil; Mycophenolate mofetil TEVA; | [2] IMPDH1 IMPDH1, IMPDH2 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [34] 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
9 |
Tocilizumab
| [1] Tocilizumab Tocilizumab | [3] ACTEMRA ACTEMRA; RoActemra; TOCILIZUMAB; | [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [21] 2 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 |
10 |
Alemtuzumab
| [1] Alemtuzumab Alemtuzumab | [4] ALEMTUZUMAB ALEMTUZUMAB; Campath; Lemtrada; MABCAMPATH; | [1] CD52 CD52 💬 | - | [22] 13 13, 15, 19, 20, 36, 43, 44, 46, 49, 51, 60, 62, 63, 65, 85, 96, 164, 234, 283, 284, 285, 326 |
11 |
Rituximab
| [1] Rituximab Rituximab | [6] MabThera MabThera; Rituxan; RITUXIMAB; Rixathon; Ruxience; Truxima; | [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [48] 11 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 |
12 |
Belimumab
| [1] Belimumab Belimumab | [2] Belimumab Belimumab; BENLYSTA; | [1] TNFSF13B TNFSF13B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [13] 11 11, 13, 43, 44, 46, 49, 51, 53, 63, 66, 222, 296, 300 |
13 |
Abatacept
| [1] Abatacept Abatacept | [2] ABATACEPT ABATACEPT; ORENCIA; | [2] CD80 CD80, CD86 💬 | [13] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [26] 11 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 |
14 |
Mepolizumab
| [1] Mepolizumab Mepolizumab | [2] Mepolizumab Mepolizumab; NUCALA; | [1] IL5 IL5 💬 | [13] Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | [4] 44 44, 45, 98, 162 |
15 |
Mycophenolic acid
| [1] Mycophenolic acid Mycophenolic acid | [5] Acido Micofenolico Acido Micofenolico; MICOFENOLICO ACIDO; Mycophenolate; Mycophenolic Acid; Myfortic; | [2] IMPDH1 IMPDH1, IMPDH2 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [36] 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 |
16 |
Naltrexone
| [1] Naltrexone Naltrexone | [2] Naltrexone Naltrexone; Naltrexone hydrochloride; | [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [13] 6 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 |
17 |
Yellow fever vaccine
| [1] Yellow fever vaccine Yellow fever vaccine | [1] Yellow fever vaccine Yellow fever vaccine; | - | - | [8] 40 40, 44, 46, 50, 51, 52, 53, 107 |
18 |
Cyclophosphamide
| [1] Cyclophosphamide Cyclophosphamide | [6] Ciclofosfamida Ciclofosfamida; Ciclofosfamide; Cyclophosphamid; Cyclophosphamide; Cyclophosphamidum; Cytoxan; | - | - | [44] 11 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 274, 283, 284, 285, 288, 326, 331 |
19 |
Gusperimus
| [1] Gusperimus Gusperimus | [1] Gusperimus Gusperimus; | - | - | [1] 44 44 |
20 |
Hydroxychloroquine
| [1] Hydroxychloroquine Hydroxychloroquine | [3] Hydroxychloroquine Hydroxychloroquine; HYDROXYCHLOROQUINE SULFATE; PLAQUENIL; | - | - | [27] 13 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 224, 234, 254, 271, 298, 299 |
21 |
Reslizumab
| [1] Reslizumab Reslizumab | [1] Reslizumab Reslizumab; | [1] IL5 IL5 💬 | [13] Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | [2] 44 44, 98 |
22 |
Obinutuzumab
| [1] Obinutuzumab Obinutuzumab | [2] GAZYVARO GAZYVARO; OBINUTUZUMAB; | [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [4] 43 43, 44, 49, 222 |
23 |
Benralizumab
| [1] Benralizumab Benralizumab | [2] Benralizumab Benralizumab; Fasenra; | [1] IL5RA IL5RA 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | [5] 44 44, 45, 98, 162, 299 |
24 |
Tofacitinib
| [1] Tofacitinib Tofacitinib | [4] Tasocitinib Tasocitinib; Tofacitinib; Xeljanz; Xeljanz XR; | [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬 | [37] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [15] 11 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 |
25 |
Blisibimod
| [1] Blisibimod Blisibimod | [1] Blisibimod Blisibimod; | - | - | [5] 43 43, 44, 49, 63, 66 |
26 |
Avacopan
| [1] Avacopan Avacopan | [1] Avacopan Avacopan; | [1] C5AR1 C5AR1 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Staphylococcus aureus infection 💬 | [3] 43 43, 44, 222 |
27 |
Vilobelimab
| [1] Vilobelimab Vilobelimab | [2] IFX-1 IFX-1; Vilobelimab; | [1] C5 C5 💬 | [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [3] 43 43, 44, 269 |